We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellexus Appoints IUL as its Exclusive Distributor in Austria, Benelux, Germany, the Netherlands and Switzerland

News   Jun 26, 2007

 
Cellexus Appoints IUL as its Exclusive Distributor in Austria, Benelux, Germany, the Netherlands and Switzerland
 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Improved Screening Strategies Help Advance Pharmaceutical Discovery

News

A new review in SLAS Discovery explores how improved safety screening strategies and methods are improving the pharmaceutical discovery and development process.

READ MORE

HTS Strategy Could Pave the Way to Parkinson’s Disease Therapy

News

Probably the single most important cause of Parkinson's disease is the aggregation of the natively unfolded protein a-synuclein (αSN). The new screening strategy enabled the team to screen 746,000 compounds for their ability to inhibit αSN aggregation.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE